{"id":"ai201901","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of AI201901 is not well understood, but it is believed to work by interacting with the molecular target, leading to a specific therapeutic effect.","oneSentence":"AI201901 is a small molecule drug that targets the molecular target.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:00:16.053Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Unknown"}]},"trialDetails":[{"nctId":"NCT04729517","phase":"PHASE3","title":"Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients","status":"COMPLETED","sponsor":"Abdi Ibrahim Ilac San. ve Tic A.S.","startDate":"2021-04-20","conditions":"Allergic Rhinitis Due to Allergens","enrollment":210}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AI201901","genericName":"AI201901","companyName":"Abdi Ibrahim Ilac San. ve Tic A.S.","companyId":"abdi-ibrahim-ilac-san-ve-tic-a-s","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AI201901 is a small molecule drug that targets the molecular target. Used for Unknown.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}